In a report released today, Jeff Van Rhee from Craig-Hallum maintained a Buy rating on Cellebrite DI (CLBT – Research Report), with a price target of $23.00. The company’s shares closed yesterday at $16.86.
According to TipRanks, Van Rhee is a 5-star analyst with an average return of 13.4% and a 53.88% success rate. Van Rhee covers the Technology sector, focusing on stocks such as Liveperson, Cellebrite DI, and Akamai.
Currently, the analyst consensus on Cellebrite DI is a Strong Buy with an average price target of $19.14, a 13.52% upside from current levels. In a report released on September 23, TD Cowen also maintained a Buy rating on the stock with a $23.00 price target.
The company has a one-year high of $17.82 and a one-year low of $6.37. Currently, Cellebrite DI has an average volume of 1.43M.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Cellebrite DI (CLBT) Company Description:
Cellebrite offers digital intelligence solutions. Its platform and solutions help law enforcement agencies (police departments, armed services, public defenders, start departments) and enterprise customers to better collect, review, analyze, and manage digital data in legally sanctioned investigations.
Read More on CLBT:
- Cellebrite price target raised to $23 from $20 at Craig-Hallum
- Cellebrite Patents its Remote Mobile Collection Capabilities for Businesses
- Cellebrite announces patent for Remote Mobile Collection
- Cellebrite price target raised to $23 from $20 at TD Cowen
- Cellebrite DI Shareholders Approve All Proposals
